|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Adagio Therapeutics (NASDAQ: ADGI) through any online brokerage.
There are no as such competitors for Adagio Therapeutics.
The latest price target for Adagio Therapeutics (NASDAQ: ADGI) was reported by Morgan Stanley on August 31, 2021. The analyst firm set a price target for 33.00 expecting ADGI to rise to within 12 months (a possible 2.96% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Adagio Therapeutics (NASDAQ: ADGI) is $32.05 last updated Mon Oct 25 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Adagio Therapeutics.
Adagio Therapeutics’s $Q3 earnings are confirmed for after-market on $November 15, 2021.
There is no upcoming split for Adagio Therapeutics.
Adagio Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.